MedPath

Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus

Not Applicable
Conditions
Type 2 Diabetes
Interventions
Other: Exercise
Registration Number
NCT04315519
Lead Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Brief Summary

Comparison of the effect of low intensity blood flow restricted aerobic exercise on glycemic and respiratory status with moderate aerobic exercise.

Detailed Description

The aim of this study is to show, whether the effect of low-intensity aerobic exercise training combined with blood flow restriction is similar on both glycemic and cardiorespiratory status compared to moderate-intensity continuous aerobic exercise, in individuals with "type 2 diabetes mellitus" .

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Having Type 2 Diabetes
  • Not have been recruited any exercise programme for 6 months
  • Volunteering to participate in the study
Exclusion Criteria
  • Nephropathy
  • Retinopathy
  • Have had myocardial infarction at least 6 months ago
  • Stable or unstable angina pectoris
  • The presence of peripheral artery disease
  • Resting blood pressure above 160/100 mmHg
  • Body mass index over 35 kg / m2
  • History of deep vein thrombosis, pulmonary embolism or stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Blood Flow Restricted Aerobic (BFRA)ExerciseLow intensity Aerobic exercise with Blood Flow Restriction
Moderate Aerobic Exercise (MAE)Exercisemoderate intensity aerobic exercise
Primary Outcome Measures
NameTimeMethod
Blood Glucoseup to 12 months

Fasting Blood Glucose, this data will be collected from the individulas routine biochemistry tests

HbA1cup to 12 months

Glycated hemoglobin, This data will be collected from teh individulas during routine test

Cardiorespiratory FitnessUp to 12 months

Maximal Power in Maximal Exercise Test, this test will be performed in incremental cardiopulmonary exercise test in cycle ergometer.

Blood Glucose in Oral glucose Tolerance TestUp to 12 months

Blood Glucose in Oral glucose Tolerance Test, this data will be collected from the individuals during routine tests.

Secondary Outcome Measures
NameTimeMethod
Fat Free MassUp to 12 months

Fat Free Mass will be calculated by bioimpedance analysis, this data will be collected with all individulas to see the changes with the muscle mass, the test will be The test will be carried out with a 4-channel test device, both hand and foot, to eveluate changes segmentally.

The Strength of Quadriceps MuscleUp to 12 months

The Strength of Quadriceps Muscle, this data will be collected before the intervention eith a manual muscle tester, in sitting position.

The Strength of Hamstring MuscleUp to 12 months

The Strength of Hamstring Muscle, this data will be collected before the intervention eith a manual muscle tester, in sitting position.

© Copyright 2025. All Rights Reserved by MedPath